References
- Alkim, H., Koksal, A. R., Boga, S., Sen, I., Alkim, C. (2017). Etiopathogenesis, prevention, and treatment of thromboembolism in inflammatory bowel disease. Clin. Appl. Thromb. Hemost., 23 (6), 501–510.10.1177/107602961663290626893444
- Bernstein, C. N., Blanchard, J. F., Houston, D. S., Wajda, A. (2001). The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb. Haemost., 85, 430–434.10.1055/s-0037-1615600
- Bokeriya, L. A., Zatevakhin, I. I., Kirienko, A. I., Andriyashkin, A. V., Andriyashkin, V. V., Arutyunov, G. P., et al. (2015). Russian clinical guidelines for the diagnosis, treatment and prevention of venous thromboembolic complications (VTEO). Phlebology, 4 (2), 4–46.
- Centers for Disease Control and Prevention (CDC). (2012). Venous thromboembolism in adult hospitalizations – United States, 2007–2009. MMWR Morb. Mortal Wkly Rep., 61, 401–404.
- Chamouard, P., Grunebaum, L., Wiesel, M. L., Frey, P. L., Wittersheim, C., Sapin, R., Baumann, R., Cazenave, J. P. (1995). Prothrombin fragment 1+2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol., 7, 1183–1188.10.1097/00042737-199512000-000108789309
- Chiarantini, E., Valanzano, R., Liotta, A. A. (1996). Hemostatic abnormalities in inflammatory bowel disease. Thromb. Res., 82, 137–146.10.1016/0049-3848(96)00060-69163067
- Danese, S., Papa, A., Saibeni, S., Repici, A., Malesci, A., Vecchi, M. (2007). Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Amer. J. Gastroenterol., 102, 174–186.10.1111/j.1572-0241.2006.00943.x17100967
- Edwards, F. C., Truelove, S. C. (1964). The course and prognosis of ulcerative colitis III complications. Gut, 5, 1–22.10.1136/gut.5.1.1155221414127503
- Algahtani, F. H., Farag, Y. M. K., Aljebreen, A. M., Alazzam, N. A., Aleem, A. S., Jabri, F. F., Rajab, M. H., Shoukri, M. M. (2016). Thromboembolic events in patients with inflammatory bowel disease. Saudi J. Gastroenterol., 22 (6), 423–427. DOI: 10.4103/1319-3767.195558.10.4103/1319-3767.195558518474227976637
- Faye, A. S., Hung, K. W., Cheng, K., Blackett, J. W., Mckenney, A. S., Pont, A. R., Li, J., Lawlor, G., Lebwohl, B., Freedberg, D. E. (2020). Minor hematochezia decreases use of venous thromboembolism prophylaxis in patients with inflammatory bowel disease. Inflamm. Bowel Dis., 26 (9), 1394–1400. DOI: 10.1093/ibd/izz269.10.1093/ibd/izz269753441431689354
- Galstyan, G. M., Polevodova, O. A., Gavrish, A. Yu., Polyanskaya, T. Yu., Zorenko, V. Yu., Sampiev, M. S., Biryukova, L. S., Model, S. V., Gorgidze, L. A., Savchenko, V. G. (2017). Thrombotic complications in patients with hemophilia. Therapeutic Arch., 89 (7), 76–84. DOI: https://doi.org/10.17116/terarkh201789776-84.10.17116/terarkh201789776-8428766545
- Grainge, M. J., West, J., Card, T. R. (2010). Venous thromboembolism during active disease and remission in inflammatory bowel disease: A cohort study. Lancet, 375, 657–663.10.1016/S0140-6736(09)61963-220149425
- Grip, O., Svensson, P. J., Lindgren, S. (2000). Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand. J. Gastroenterol., 35, 619–623.10.1080/00365520075002358910912662
- Harvey, R. F., Bradshaw, J. M. (1980). A simple index of Crohn’s-disease activity. Lancet, 315 (8167), 514.10.1016/S0140-6736(80)92767-16102236
- Heits, F., Stahl, M., Ludwig, D., Strange, E. F., Jelkmann, W. (1999). Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J. Interferon Cytokine Res., 19, 757–760.10.1089/10799909931360410454346
- Horsted, F., West, J., Grainge, M. J. (2012). Risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis. PLoS Med., 9, e1001275.10.1371/journal.pmed.1001275340913022859911
- Ivashkin, V. T., Shelygin, Yu. A., Belousova, E. A., Abdulganieva, D. I., Alekseeva, O. A., Achkasov, S. I., Valuyskikh, E. Y., Vardanyan, A. V., Veselov, A. V., Veselov, V. V., et al. (2019). Draft Clinical Guidelines for the Diagnosis and Treatment of Ulcerative Colitis. Coloproctology, 18 (4), 7–36. https://doi.org/10.33878/2073-7556-2019-18-4-7-36.10.33878/2073-7556-2019-18-4-7-36
- Jelkmann, W. (1998). Proinflammatory cytokines lowering erythropoietin production. J. Interferon Cytokine Res., 18, 555–559.10.1089/jir.1998.18.5559726435
- Khatkov, I. E., Parfenov, A. I., Knyazev, O. V., Mikhailants, G. S., Atroshchenko, A. O., Ruchkina, I. N. (2017). Inflammatory Bowel Diseases in the Practice of a Therapist and Surgeon. Vita-Press, 120 pp.
- Koutroubakis, I. E. (2005). Therapy insight: Vascular complications in patients with inflammatory bowel disease. Nat. Clin. Pract. Gastroenterol. Hepatol., 2, 266–272.10.1038/ncpgasthep019016265230
- Kuznetsova, B. A., Bokarev, I. N. (eds.) (2011). Laboratory Methods of Studying the System of Blood Coagulation. Ministry of Health and Social Development, Moscow.
- Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., Eichinger, S. (2000). High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. New Engl. J. Med., 343, 457–462.10.1056/NEJM20000817343070210950667
- Lijfering, W., Rosendaal, F., Cannegieter, S. (2010). Risk factors for venous thrombosis-current understanding from an epidemiological point of view. Brit. J. Haematol., 149 (6), 824–833, DOI: 10.1111/j.1365-2141.2010.08206.
- Magro, F., Soares, J. B., Fernandes, D. (2014). Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J. Gastroenterol., 20, 4857–4872.10.3748/wjg.v20.i17.4857400951724803797
- Nguyen, G. C., Bernstein, C. N., Bitton, A., Chan, A. K., Griffiths, A. M., Leontiadis, G. I., Geerts, W., Bressler, B., Butzner, J. D., Carrier, M., et al. (2014). Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology, 146, 835–848.10.1053/j.gastro.2014.01.04224462530
- Nguyen, G. C., Sam, J. (2008). Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Amer. J. Gastroenterol., 103 (9), 2272–2280. DOI: 10.1111/j.15720241.2008.02052.x.
- Sands, B. E., Bank, S., Sninsky, C. A., Robinson, M., Katz, S., Singleton, J. W., Miner, P. B., Safdi, M. A., Galandiuk, S., Hanauer, S. B., et al. (1999). Preliminary evaluation of safety and activity of recombinant human interleukin-11 in patients with active Crohn’s disease. Gastroenterology, 117, 58–64.10.1016/S0016-5085(99)70550-0
- Schreiber, S., Howaldt, S., Schnoor, M., Nikolaus, S., Bauditz, J., Gasché, C. Lochs, H., Raedler, A. (1996). Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. New Engl. J. Med., 334, 619–623.10.1056/NEJM1996030733410028592524
- Sloan, W. P., Jr, Bargen, J. A., Gage, R. P. (1950). Life histories of patients with chronic ulcerative colitis: A review of 2,000 cases. Gastroenterology, 16, 25–38.10.1016/S0016-5085(19)36591-6
- Solem, C. A., Loftus, E. V., Tremaine, W. J., Sandborn, W. J. (2004). Venous thromboembolism in inflammatory bowel disease. Amer. J. Gastroenterol., 9, 97–101.10.1046/j.1572-0241.2003.04026.x14687149
- Spina, L., Saibeni, S., Battaglioli, T., Peyvandi, F., de Franchis, R., Vecchi, M. (2005). Thrombosis in inflammatory bowel diseases: Role of inherited thrombophilia. Amer. J. Gastroenterol., 100, 2036–4116.10.1111/j.1572-0241.2005.42029.x16128949
- Ferrer, C. S., Mendoza, M. I. V., Román, L. A. S.,, Lama, Y. G., Moya, M. C., Casas, M. G., García, L. A. Risk of thromboembolic phenomena in patients with inflammatory bowel disease. Gastroenterol. Hepatol., 35, 634–639 (in Spanish).
- Talbot, R. W., Heppell, J., Dozois, R. R., Beart, R. W. Jr. (1986). Vascular complications of inflammatory bowel disease. Mayo Clin. Proc., 61, 140–145.10.1016/S0025-6196(12)65200-8
- Stomenskaya, I. S. et al. (2017). Thromboelastometry is a method of laboratory diagnostics of disorders of the hemostasis system. Med. Almanac, 47 (2), 96–98. DOI: 10.21145/2499-9954-2017-2-96-98.10.21145/2499-9954-2017-2-96-98
- Twig, G., Zandman-Goddard, G., Szyper-Kravitz, M., Shoenfeld, Y. (2005). Systemic thromboembolism in inflammatory bowel disease: Mechanisms and clinical applications. Ann. NY Acad. Sci., 1051, 166–173.10.1196/annals.1361.05816126956
- Yuhara, H., Steinmaus, C., Corley, D., Koike, J., Igarashi, M., Suzuki, T., Mine, T. (2013). Meta-analysis: The risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol. Ther., 37 (10), 953–962. DOI: 10.1111/apt.12294.10.1111/apt.1229423550660